Journal Information
Vol. 43. Issue. S2.December 2023
Special Issue December
Pages 1-138
Vol. 43. Issue. S2.December 2023
Special Issue December
Pages 1-138
Letter to the Editor
Full text access
Reversible posterior encephalopathy syndrome in the course of massive pleuroperitoneal leakage in a patient on peritoneal dialysis
Síndrome de encefalopatía posterior reversible en el transcurso de fuga pleuroperitoneal masiva en una paciente en diálisis peritoneal
Visits
1037
Montserrat Picazo Sánchez
Corresponding author
mpicazo@salutemporda.cat

Corresponding author.
, Marc Cuxart Pérez, Rosa Masdeu Jufré, Maria Cufí Vallmajor
Fundacio Salut Emporda, Figueres, Girona, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Special issue
This article is part of special issue:
Vol. 43. Issue S2

Special Issue December

More info
Full Text
Dear Editor,

Pleuroperitoneal leak (PL) is an uncommon complication in peritoneal dialysis (PD), with an estimated incidence of less than 2%,1–3 but leading to a large proportion of patients abandoning the technique.3

There are multiple predisposing factors including diaphragmatic muscle hypotonia, congenital diaphragmatic defects, increased pleuroperitoneal pressure gradients, as may occur in polycystic kidney disease, and impaired lymphatic drainage.1,4

Clinically, PL manifests as dyspnoea of more or less sudden onset, loss of ultrafiltration and pleural effusion3, but there are no cases in the literature with the reason for consultation being an episode of seizures due to posterior reversible encephalopathy syndrome (PRES) when performing PD and in which there was a massive PL.

We present the case of a 24-year-old woman with chronic renal failure due to IgA mesangial nephropathy on continuous ambulatory peritoneal dialysis for one month, who was transferred to the emergency department due to intense headache and blurred vision with subsequent loss of consciousness and generalised tonic-clonic movements while undergoing PD replacement. Her previous medical history also included obesity, with a BMI of 32, and hypertension controlled with enalapril and furosemide. The patient subsequently suffered two more episodes of seizures and her blood pressure (BP) was 260/112 mmHg and O2 saturation 87%. The recent history reported by the family included a decrease in peritoneal drainage balances and right rib pain for 2–3 days, and worse control of her BP with values of 165/100 mmHg. She was initially received oxygen therapy, intravenous labetalol, clonazepam and levetiracetam, with a gradual decrease in blood pressure. Further tests included a chest X-ray, showing massive right pleural effusion (Fig. 1), blood tests, showing electrolytes to be normal, normal brain CT scan, lumbar punction with no evidence of infection and eye fundi with preserved macula in both eyes, with no exudates or haemorrhages suggestive of hypertensive retinopathy. Analysis of the pleural fluid was compatible with transudate, with glucose levels higher than plasma blood glucose. With the diagnosis of a massive right pleuroperitoneal leak and given the severity of the patient's clinical condition, a right jugular catheter was inserted and haemodialysis with progressive ultrafiltration started, with recovery of consciousness, gradual decrease in pleural effusion and optimisation of BP control. MRI of the brain at 24 h showed lesions compatible with PRES. Ten days later, a peritoneal scintigraphy showed, 90 min after administration of the radiotracer, diffuse passage of the radiotracer to the right posterior pleural region, occupying a large part of the right thoracic region and causing the patient right pleuritic pain and dyspnoea. We decided to definitively discontinue the PD.

Figure 1.

Massive right pleural effusion.

(0.03MB).

Although there are numerous published cases of PRES in patients with renal failure, many of them on haemodialysis, few cases have been reported in patients on PD. Virtually all of them had seizures as an initial symptom, and volume overload and poor compliance with dialysis were the main contributing or aggravating factors.5,6 In a review of the literature we did not find any cases in which PL was the triggering cause of PRES.

Conservative treatment of PL is effective in approximately 50% of patients.5 In the case we present here, the severity of the symptoms and the suspicion of a possible diaphragmatic defect led us to definitively discontinue PD. Progressive ultrafiltration through intensification of the haemodialysis programme achieved resolution of the PRES and PL.

References
[1]
M.H. Dang, M. Mathew, R. Raj.
Pleuroperitoneal Leak as an Uncommon Cause of Pleural Effusion in Peritoneal Dialysis: A Case Report and Literature Review.
Case Rep Nephrol, 2020 (2020),
[2]
Y. Nomoto, T. Suga, K. Nakajima, H. Sakai, G. Osawa, K. Ota, et al.
Acute hydrothorax in continuous ambulatory peritoneal dialysis--a collaborative study of 161 centers.
Am J Nephrol, 9 (1989), pp. 363-367
[3]
R. Díaz, G. del Peso, M. Rodríguez, B. Fernández, M. Ossorio, M.A. Bajo, et al.
Comunicación pleuro-peritoneal en pacientes en diálisis peritoneal. Experiencia en un centro y revisión de la literatura.
[4]
C. Kennedy, C. McCarthy, S. Alken, J. McWilliams, R.K. Morgan, M. Denton, et al.
Pleuroperitoneal leak complicating peritoneal dialysis: a case series.
Int J Nephrol, 2011 (2011),
[5]
M. Moreiras, F. Fernández, N. Azkárate Ramírez, W. Nájera de la Garza, I. Martín-Báez, M. Hernansanz-Pérez.
Diálisis peritoneal: ¿un factor de riesgo o de protección para la encefalopatía posterior reversible (PRES)? Revisión de la literatura.
Nefrología, 38 (2018), pp. 136-140
[6]
S. Kaneko, K. Hirai, S. Minato, K. Yanai, Y. Mutsuyoshi, H. Ishii, et al.
A case of posterior reversible encephalopathy syndrome in a patient undergoing automated peritoneal dialysis.
CEN Case Rep, 8 (2019), pp. 178-182
Copyright © 2022. Sociedad Española de Nefrología
Download PDF
Idiomas
Nefrología (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?